# GENCLIS SA

> RNA-DNA sequence divergence mechanism


## About GENCLIS SA

Research and development of Transcription Infidelity, a patented biological mechanism affecting RNA-DNA sequence divergence and protein immunogenicity.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1–10 employees
- **Headquarters**: Vandœuvre-lès-Nancy, Grand Est, France
- **Founded**: 2004
- **Revenue**: €2.8M – €21.9M (Tamtam estimate)
- **Website**: [genclis.com](https://www.genclis.com/)
- **LinkedIn**: [linkedin.com/company/genclis-sa](https://www.linkedin.com/company/genclis-sa)

## GENCLIS SA at a glance

GENCLIS SA is a company in the Biotechnology Research industry, headquartered in Vandœuvre-lès-Nancy, Grand Est, France.

GENCLIS SA was founded in 2004.

GENCLIS SA has 1–10 employees.

GENCLIS SA's revenue is €2.8M – €21.9M (Tamtam estimate).

## Frequently asked questions about GENCLIS SA

### What is GENCLIS SA's revenue?

Tamtam estimates GENCLIS SA's annual revenue at €2.8M – €21.9M.

### How many employees does GENCLIS SA have?

GENCLIS SA has 1–10 employees.

### Where is GENCLIS SA headquartered?

GENCLIS SA is headquartered in Vandœuvre-lès-Nancy, Grand Est, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/genclis-sa